RHINO 7 Platinum 5000 recalled over undeclared active
- Recall date
- September 15, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Gadget Island, Inc recalls RHINO 7 Platinum 5000, capsule, Proprietary Material: 750mg, 1-capsule packets, distributed by Fifty Shades Bayside, NY…
- Recall number
- D-0103-2018
- FDA classification
- Class I
- Brand / firm
- Gadget Island, Inc
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
RHINO 7 Platinum 5000, capsule, Proprietary Material: 750mg, 1-capsule packets, distributed by Fifty Shades Bayside, NY 11361, UPC 617135861224
Get recall alerts
Free email alert whenever Gadget Island, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Gadget Island, Inc